Dr. Michael Hammer, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $121,955 | 61 | 77.4% |
| Travel and Lodging | $13,225 | 69 | 8.4% |
| Food and Beverage | $13,004 | 533 | 8.2% |
| Consulting Fee | $9,400 | 5 | 6.0% |
| Education | $55.50 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $77,462 | 311 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $51,919 | 92 | $0 (2023) |
| UCB, Inc. | $16,855 | 93 | $0 (2024) |
| Neos Therapeutics, LP | $7,169 | 14 | $0 (2017) |
| Eisai Inc. | $1,133 | 40 | $0 (2021) |
| LivaNova USA, Inc. | $881.33 | 20 | $0 (2021) |
| Neurelis, Inc. | $449.42 | 17 | $0 (2023) |
| Shire North American Group Inc | $384.70 | 30 | $0 (2019) |
| Lundbeck LLC | $325.32 | 9 | $0 (2018) |
| Corium, LLC | $285.48 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $724.22 | 5 | UCB, Inc. ($724.22) |
| 2023 | $3,374 | 24 | UCB, Inc. ($2,994) |
| 2022 | $17,117 | 66 | Supernus Pharmaceuticals, Inc. ($13,887) |
| 2021 | $20,975 | 89 | Supernus Pharmaceuticals, Inc. ($14,937) |
| 2020 | $16,320 | 55 | Ironshore Pharmaceuticals Inc. ($10,143) |
| 2019 | $41,528 | 155 | Ironshore Pharmaceuticals Inc. ($39,914) |
| 2018 | $19,638 | 137 | Supernus Pharmaceuticals, Inc. ($18,470) |
| 2017 | $37,964 | 145 | Supernus Pharmaceuticals, Inc. ($29,577) |
All Payment Transactions
676 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $115.48 | General |
| Category: Neurology | ||||||
| 04/23/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $128.17 | General |
| Category: Neurology | ||||||
| 04/19/2024 | UCB, Inc. | Briviact (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Neurology | ||||||
| 01/30/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Neurology | ||||||
| 01/23/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $65.57 | General |
| Category: Neurology | ||||||
| 11/20/2023 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/16/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/08/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $118.68 | General |
| Category: Neurology | ||||||
| 10/31/2023 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: Neurology | ||||||
| 08/10/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/05/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Neurology | ||||||
| 06/15/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: EPILEPSY | ||||||
| 06/08/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: NEUROLOGY | ||||||
| 06/01/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/11/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Neurology | ||||||
| 04/27/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Neurology | ||||||
| 04/13/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Neurology | ||||||
| 04/11/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $112.15 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/06/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/23/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/21/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: PSYCHOLOGY | ||||||
| 03/10/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Neurology | ||||||
| 02/23/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Neurology | ||||||
| 02/16/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: EPILEPSY | ||||||
About Dr. Michael Hammer, MD
Dr. Michael Hammer, MD is a Neurology with Special Qualifications in Child Neurology healthcare provider based in Saint Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508808759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hammer, MD has received a total of $157,639 in payments from pharmaceutical and medical device companies, with $724.22 received in 2024. These payments were reported across 676 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($121,955).
Practice Information
- Specialty Neurology with Special Qualifications in Child Neurology
- Other Specialties Neurology with Special Qualifications in Child Neurology, Neurology with Special Qualifications in Child Neurology
- Location Saint Petersburg, FL
- Active Since 06/12/2006
- Last Updated 04/10/2024
- Taxonomy Code 2084N0402X
- Entity Type Individual
- NPI Number 1508808759
Products in Payments
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $39,914
- QELBREE (Drug) $28,757
- OXTELLAR XR (Drug) $26,841
- TROKENDI XR (Drug) $21,827
- JORNAY PM (Drug) $12,005
- Adzenys XR-ODT (Drug) $7,169
- Briviact (Drug) $5,552
- Nayzilam (Drug) $4,429
- Fycompa (Drug) $1,133
- VNS Therapy (Device) $980.95
- VYVANSE (Drug) $577.70
- VALTOCO (Drug) $449.42
- Vimpat (Drug) $404.75
- Fintepla (Drug) $374.22
- ONFI (Drug) $325.32
- Azstarys (Drug) $199.13
- Epidiolex (Drug) $141.07
- AZSTARYS (Drug) $86.35
- APTIOM (Drug) $70.17
- MYDAYIS (Drug) $47.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology with Special Qualifications in Child Neurology Doctors in Saint Petersburg
Angel Hernandez, Md, MD
Neurology with Special Qualifications in Child Neurology — Payments: $2,099
Richard Kanoff
Neurology with Special Qualifications in Child Neurology — Payments: $376.82
Robert Kropp, M.d, M.D
Neurology with Special Qualifications in Child Neurology